News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Daily News Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds Caitlin E. Cox January 18, 2018
News Daily News CTA Reduces MI Compared With Functional Stress Testing, but at a Cost Michael O'Riordan October 05, 2017
News Daily News Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis Yael L. Maxwell August 14, 2017
News Daily News ‘Constellation of Cardiovascular Stressors’ Puts Firefighters at Risk for MI L.A. McKeown April 03, 2017
News Daily News Statin-Intolerant Patients Have Significantly Worse Prognosis After MI Michael O'Riordan March 13, 2017
News Daily News Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy Michael O'Riordan January 18, 2017
News Features Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter Michael O'Riordan January 10, 2017
News Daily News High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds Todd Neale December 19, 2016
News Daily News Smoking and Acute MI: The Younger the Patient, the Higher the Risk L.A. McKeown December 02, 2016
News Daily News Prevention Efforts Seem to Be Paying Off as Acute MIs Continue Slide Todd Neale August 08, 2016
News Daily News Los Esfuerzos en Materia de Prevención Empiezan a Dar sus Frutos Con Índices IAM en Descenso Todd Neale August 08, 2016
News Daily News La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad Michael O'Riordan May 17, 2016
News Daily News Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates Michael O'Riordan May 17, 2016
News Daily News New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin Caitlin E. Cox March 23, 2016
News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016